Skip to main content

Table 2 GRADE assessment for PCA morphine compared to IV morphine

From: Patient-controlled analgesia morphine for the management of acute pain in the emergency department: a systematic review and meta-analysis

Outcomes

№ of participants

(studies)

Follow-up

Certainty of the evidence

(GRADE)

Relative effect

(95% CI)

Anticipated absolute effects

Risk with IV morphine

Risk difference with PCA morphine

Patient satisfaction

1166

(5 RCTs)

High

not estimable

734 per 1,000

734 fewer per 1,000

(734 fewer to 734 fewer)

Number of patients requiring additional analgesia

760

(3 RCTs)

Moderatea

OR 0.47

(0.34 to 0.64)

387 per 1,000

158 fewer per 1,000

(210 fewer to 99 fewer)

Adverse effect:

Nausea/Vomiting

684

(5 RCTs)

Moderatea

OR 1.25

(0.82 to 1.90)

214 per 1,000

40 more per 1,000

(32 fewer to 127 more)

Pain

1405

(8 RCTs)

Moderateb

-

-

SMD 0.2 lower

(0.55 lower to 0.14 higher)

Pain by dosage - Low dosage (less than 1 mg)

166

(2 RCTs)

Moderatea

-

-

SMD 0.36 lower

(0.67 lower to 0.06 lower)

Pain by dosage - High dosage (more than 1 mg)

179

(2 RCTs)

Moderatea

-

-

SMD 0.38 lower

(0.68 lower to 0.09 lower)

Pain by intervals - Pain measured at 120 min

868

(3 RCTs)

Moderateb

-

-

SMD 0.3 lower

(1.08 lower to 0.49 higher)

  1. RCT randomized controlled trial, PCA patient-controlled analgesia, IV intravenous, CI confidence interval, MD mean difference, OR odds ratio, SMD standardised mean difference, a The number of events less than 400, b I square more than 50%